Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation
Public ClinicalTrials.gov record NCT00080236. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Safety, Tolerability and Efficacy Study of a Caspase Inhibitor, IDN-6556, in Patients Undergoing Orthotopic Liver Transplantation (OLT)
Study identification
- NCT ID
- NCT00080236
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Conatus Pharmaceuticals Inc.
- Industry
- Enrollment
- 99 participants
Conditions and interventions
Interventions
- IDN-6556 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2003
- Primary completion
- Dec 31, 2005
- Completion
- Dec 31, 2005
- Last update posted
- Aug 9, 2012
2003 – 2006
United States locations
- U.S. sites
- 10
- U.S. states
- 8
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic Scottsdale | Phoenix | Arizona | 85054 | — |
| University of California Los Angeles | Los Angeles | California | 90095 | — |
| University of California San Francisco | San Francisco | California | 94143 | — |
| Indiana University Medical Center | Indianapolis | Indiana | 46202 | — |
| Tulane University Hospital and Clinic | New Orleans | Louisiana | 70112 | — |
| Mayo Clinic Rochester | Rochester | Minnesota | 55905 | — |
| Mount Sinai School of Medicine | New York | New York | 10029 | — |
| University of Cincinnati | Cincinnati | Ohio | 45267 | — |
| Baylor Regional Transplant Institute, Baylor University Medical Center | Dallas | Texas | 75246 | — |
| The University of Texas Health Science Center at San Antonio | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00080236, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 9, 2012 · Synced May 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00080236 live on ClinicalTrials.gov.